Dear colleagues,
Our priority is to keep attendees, faculty and sponsors safe. Given the continuing uncertainties related to the Covid-19 pandemic, EUROGIN 2021 is going to be fully virtual this year.
This means EUROGIN’s unrivalled content will remain identical as planned for the face-to-face event. In fact, delegates will have access to a wider range of presentations, as it will be possible to navigate through different program streams at any time during the congress, and benefit from exclusive access to all presentations for 4 months after the conference.
We are also happy to welcome participants from around the world who would be unable to travel and will now have the opportunity to join for a full EUROGIN experience.
We look forward to welcoming you to EUROGIN 2021 on our virtual conference platform on May 30 - June 1.
Best wishes and keep safe,
The EUROGIN Organizing Committee
The EUROGIN HPV and Head & Neck Cancer Forum highlights recent advances and areas of active research in the field of HPV-related head and neck cancers. This year’s Forum features the emerging role of biomarkers in screening and management of HPV-related oropharyngeal cancer, updates from deintensification trials and other therapeutic innovations, and a dedicated session focusing on molecular & immunologic considerations.
Advance registration rate will be available until April 27, 2021.
Final rate will be available from April 28, 2021.
For sponsorship and exhibition enquiries, please contact Peter Mattonet: [email protected]
The EUROGIN congress has been vetted as COMPLIANT by the Ethical Med Tech conferene vetting system on all assessment criteria:
EUROGIN (EUropean Research Organisation on Genital Infection and Neoplasia) brings together clinicians and scientists whose work is related to genital infections and neoplasia.
TRUSTED PARTNER
